Table 4 Transfusion frequency in different patient cohorts.
Predictor | n | % | p |
|---|---|---|---|
Age | |||
≤ 66 years (median) | 3/157 | 1.9 | 0.066 |
> 66 years (median) | 9/151 | 6.0 | |
< 75 years | 5/217 | 2.3 | 0.026 |
≥ 75 years | 7/91 | 7.7 | |
BMI | |||
< 28 (median) | 9/155 | 5.8 | 0.081 |
≥ 28 (median) | 3/153 | 2.0 | |
< 30 | 12/196 | 6.1 | 0.008 |
≥ 30 | 0/112 | 0.0 | |
ASA | |||
≤ 2 | 6/238 | 2.5 | 0.02 |
> 2 | 6/69 | 8.7 | |
Anticoagulation | |||
Yes | 6/87 | 6.9 | 0.088 |
No | 6/221 | 2.7 | |
Anticoagulation | |||
No | 6/221 | 2.7 | 0.001 |
Platelet inhibitor | 2/49 | 4.1 | |
DOAC | 1/27 | 3.7 | |
VKA | 3/11 | 27.3 | |
Mechanical heart valve | |||
Yes | 2/3 | 66.7 | 0.004 |
No | 10/305 | 3.3 | |
Operation | |||
Knee arthroplasty | 2/79 | 2.5 | 0.367 |
Hip arthroplasty | 10/202 | 5.0 | |
Hip arthroplasty | |||
Standard lateral approach | 8/127 | 6.3 | 0.328 |
Minimal invasive anterolateral approach | 2/75 | 2.7 | |
Drains | |||
Yes | 11/136 | 8.1 | 0.001 |
No | 1/171 | 0.6 | |
Tranexamic acid | |||
Yes | 1/118 | 0.8 | 0.029 |
No | 11/190 | 5.8 | |
Tranexamic acid | |||
Drain | 1/38 | 2.6 | 0.001 |
No drain | 0/80 | 0.0 | |
No tranexamic acid | |||
Drain | 10/98 | 10.2 | |
No drain | 1/91 | 1.1 | |
Hemoglobin < 11.0 g/dL | |||
Yes | 4/6 | 66.7 | < 0.001 |
No | 8/302 | 2.6 | |
Hemoglobin < 12.0 g/dl | |||
Yes | 6/26 | 23.1 | < 0.001 |
No | 6/282 | 2.1 | |
Hemoglobin < 13.0 g/dL | |||
Yes | 10/97 | 10.3 | < 0.001 |
No | 2/211 | 0.9 | |
Hemoglobin < 14.0 g/dL | |||
Yes | 10/165 | 6.1 | 0.035 |
No | 2/143 | 1.4 | |
GFR < 60 mL/min | |||
Yes | 3/47 | 6.4 | 0.348 |
No | 9/258 | 3.5 | |
MCHC < LLN | |||
Yes | 2/5 | 40.0 | 0.013 |
No | 10/303 | 3.3 | |